NCT04882150View on ClinicalTrials.gov

A Study to Determine the Safety, Drug Levels and Drug Effects of BMS-986196 and Food and Formulation Effects on Relative Absorption Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

June 10, 2022

Study Completion Date

June 10, 2022

Conditions
Healthy Participants
Interventions
DRUG

BMS-986196

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (1)

84124

Local Institution - 0002, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04882150 - A Study to Determine the Safety, Drug Levels and Drug Effects of BMS-986196 and Food and Formulation Effects on Relative Absorption Healthy Participants | Biotech Hunter | Biotech Hunter